Research Article
Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study
Figure 1
Details about MMF use. (a) Distribution of reasons for MMF discontinuation. (b) The Kaplan-Meier curve for MMF discontinuation. (c) The Kaplan-Meier curve for MMF discontinuation due to adverse events. (d) MMF dose at last observation. MMF: mycophenolate mofetil.
(a) |
(b) |
(c) |
(d) |